Auckland Clinical Studies Limited

Grafton 1010

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early
• A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants — Stopped early